Heartflow Inc
HTFL
NASDAQ
Health Care
$41.94
USD
-0.14 (-0.33%)
At close: Aug 17, 2026, 4:00 PM EDT
Market Cap $2.67B
Volume 4.1M
About Heartflow Inc
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The company is headquartered in Mountain View, California and currently employs 843 full-time employees. The company went IPO on 2025-08-08. The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
CEO
Mr. John Farquhar
HQ
Mountain View, CALIFORNIA, US
Founded
2025
Employees
843
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
5 metrics our research team weighs before forming a view on HTFL.
Based on Quantli research · SEC filings · as of Q2 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Gross Margin (TTM)
80.1%
—
Operating Margin (TTM)
-37.8%
—
Net Margin (TTM)
-55.8%
—
ROE (TTM)
-42.3%
—
Free Cash Flow (TTM)
$-59.18M
—
Financial Snapshot
Revenue
$212.07M
— YoY
Gross Margin
80%
TTM
— YoY
Net Income
$-118.37M
— YoY
Operating Cash Flow
$-52.23M
— YoY
Key Statistics
Open
$41.23
Previous Close
$42.08
Day Range
$41.00 - $43.28
52 Week Range
$20.13 - $43.28
Volume
4.1M
Average Volume (10 Days)
1.8M
Dividend Yield
—
Valuation Measurement
Market Cap
$2.67B
P/E Ratio (TTM)
—
P/S Ratio (TTM)
12.61
Price / Book
9.56
Financial Highlights
Profit Margin
-55.8%
Return on Assets
-34.4%
Return on Equity
-42.3%
Revenue (TTM)
$212.07M
Net Income (TTM)
$-118.37M
Diluted EPS (TTM)
-$1.82
Total Cash (MRQ)
$34.36M
Levered FCF (TTM)
$-59.18M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 10
Est. EPS
Adjusted consensus estimate
-$0.11
Analyst Consensus
Based on 3 analyst ratings
Avg Target: $38.67
(-7.8% upside)
High: $45.00 · Low: $34.00
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%